Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Boyd

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Genesis (New York, N.Y. : 2000)|September 20, 2008
Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout miceShannon L Duffy, Mark G Coulthard, Mark D Spanevello, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2017
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastomaRoger Gilabert-Oriol, Sebastian G B Furness, Brett W Stringer, et al.
Plos One|February 8, 2013
EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)Kathryn M Munro, Kirsty J Dixon, Melissa M Gresle, et al.
The Journal of Biological Chemistry|June 18, 2011
Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein productsElham Sadeqzadeh, Charles E de Bock, Xu Dong Zhang, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Cells|January 25, 2020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D CultureRochelle C J D'Souza, Carolin Offenhäuser, Jasmin Straube, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Genesis (New York, N.Y. : 2000)|September 20, 2008
Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout miceShannon L Duffy, Mark G Coulthard, Mark D Spanevello, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2017
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastomaRoger Gilabert-Oriol, Sebastian G B Furness, Brett W Stringer, et al.
Plos One|February 8, 2013
EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)Kathryn M Munro, Kirsty J Dixon, Melissa M Gresle, et al.
The Journal of Biological Chemistry|June 18, 2011
Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein productsElham Sadeqzadeh, Charles E de Bock, Xu Dong Zhang, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Cells|January 25, 2020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D CultureRochelle C J D'Souza, Carolin Offenhäuser, Jasmin Straube, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Pageof 7